LemnaTec

Contact
lemnatec.de
+4924054126-0

LemnaTec GmbH

Schumanstraße 18
52146 Würselen
Germany
+4924054126-0
lemnatec.de
Contact
Profile Products
Contact

About LemnaTec

LemnaTec is an innovative company in image processing for ecotoxicology, high-throughput screening, healthcare and biotechnology purposes. The LemnaTec team combines engineering and scientific competences. Together with leading scientists in medical and biological research LemnaTec develops integrated evaluation methods based on optical recognition and statistical analysis. The LemnaTec products meet all requirements from dose-response bioassay analysis to big high-throughput screening systems for both plants and small-animal testing from 96-well plates to 2 m plants in pots.

Read more about LemnaTec
Facts about LemnaTec
  • Focus : Manufacturer
  • Industry : IT

Product portfolio of LemnaTec

Product portfolio

Show all

Similar companies

GUS ERP GmbH

GUS ERP GmbH

Köln
Manufacturer
Production technology
IT
Search companies
GUS ERP GmbH

GUS ERP GmbH

Köln
Manufacturer
Production technology
IT
Search companies

Here you will find LemnaTec GmbH

Last viewed contents

LemnaGene SA - Dardilly, France

LemnaGene SA - Dardilly, France

Go to page
SPX Flow Technology Norderstedt GmbH - Löhne, Germany

SPX Flow Technology Norderstedt GmbH - Löhne, Germany

Go to page

Stockholm-Uppsala Professor receives prestigious cardiovascular award - Prof Lars Wallentin awarded Gold Medal at the European Society of Cardiology Congress 2010

Go to page

Pharmexa obtains global license to Provax® from Biogen Idec

Go to page

Innogenetics NV to distribute genetic testing products in Europe for Third Wave Technologies Inc.

Go to page

University of Nottingham and BioFocus sign compound management agreement

Go to page

Teva and Lonza Announce Strategic Partnership

Go to page

Cellectis receives the 2009 INPI National Innovation Award

Go to page

Agilent teams with Battelle Memorial Institute to develop artificial neural network technology for protein research with LC/MS

Go to page

Roche to launch publicly accessible databases for clinical trials - Enhanced transparency through electronic databases for clinical trial protocol registration and reporting of results

Go to page

VCU EXPERTS IDENTIFY KEY MOLECULAR PLAYERS INVOLVED IN THE PATHOGENESIS OF LYME DISEASE

Go to page

Clayton, Dubilier & Rice Completes Acquisition of VWR International for $1.65 Billion - VWR International will continue to distribute Merck laboratory products

Go to page